Human Campylobacteriosis in Italy: Emergence of Multi-Drug Resistance to Ciprofloxacin, Tetracycline, and Erythromycin.
Aurora García-Fernández,Anna Maria Dionisi,Sergio Arena,Yaidelys Iglesias-Torrens,Alessandra Carattoli,Ida Luzzi +5 more
TLDR
An increasing percentage of Campylobacter coli strains simultaneously resistant to ciprofloxacin, tetracycline and erythromycin has been found and molecular mechanisms of resistance have been investigated and the role of efflux pumps evaluated.Abstract:
Campylobacter spp. is one of the main cause of bacterial gastroenteritis in the world. The increase of antibiotic resistance in this species is a threat to public health. A Campylobacter spp. surveillance study was performed in Italy in the 2013-2016 period by the Enter-Net Italia network. The most prevalent Campylobacter species identified causing gastroenteritis was C. jejuni (73.4%) and 45% of all the annual cases of campylobacteriosis were reported in the summer period. High rates of ciprofloxacin and tetracycline resistance in Campylobacter spp. have been observed. An increasing percentage of C. coli strains simultaneously resistant to ciprofloxacin, tetracycline and erythromycin has been found. Molecular mechanisms of resistance have been investigated and the role of efflux pumps evaluated. Antibiotic resistance in Campylobacter spp. is an increasing serious threat that requires coordinated action to minimize the emergence and spread of antimicrobial resistant strains from animals to humans throughout the food chain.read more
Citations
More filters
Journal ArticleDOI
Antibiotics bioremediation: Perspectives on its ecotoxicity and resistance.
Mohit Kumar,Shweta Jaiswal,Kushneet Kaur Sodhi,Pallee Shree,Dileep K. Singh,Pawan Kumar Agrawal,Pratyoosh Shukla +6 more
TL;DR: The present review focuses on the environmental sources of antibiotics, it's possible degradation mechanisms, health effects, and bacterial antibiotics resistance mechanisms, and the antibiotic degradation and elimination from the environment and its health benefits.
Journal ArticleDOI
New and alternative strategies for the prevention, control, and treatment of antibiotic-resistant Campylobacter.
TL;DR: Campylobacter-associated disease spectrums and current treatment options are described, the state of antibiotic resistance and alternative therapies are discussed, and various approaches that are being developed to control Campylobacteria infections in animal reservoirs and the human host are evaluated.
Journal ArticleDOI
Antibiotic resistance in the environment: a critical insight on its occurrence, fate, and eco-toxicity.
Sakina Bombaywala,Sakina Bombaywala,Ashootosh Mandpe,Ashootosh Mandpe,Sonam Paliya,Sonam Paliya,Sunil Kumar,Sunil Kumar +7 more
TL;DR: In this paper, a review of literature providing guidelines for the articulation of policies for prudent use of antibiotics, limits on the amount of antibiotics in pharmaceutical formulations, and regular surveillance in the Indian context is presented.
Journal ArticleDOI
Prevalence, Virulence, and Antimicrobial Resistance of Campylobacter spp. in Raw Milk, Beef, and Pork Meat in Northern Poland.
TL;DR: Pasteurized milk, beef, and pork available for sale in the Kujawsko-Pomorskie and Wielkopolska regions in Poland are contaminated with Campylobacter bacteria and may be a potential source of infection.
Journal ArticleDOI
Perspectives on the antibiotic contamination, resistance, metabolomics, and systemic remediation
Kushneet Kaur Sodhi,Mohit Kumar,Mohit Kumar,Biji Balan,Amit S. Dhaulaniya,Pallee Shree,Nitika Sharma,Dileep K. Singh +7 more
TL;DR: In this paper, the authors present a review of antibiotic contamination and antibiotic resistance in agriculture, aquaculture, human, and livestock using mass-spectrometry-based techniques and a novel approach of creating a database for systemic remediation and metabolomics for the cleaner and safer environment.
References
More filters
Performance standards for antimicrobial susceptibility testing
TL;DR: The supplemental information presented in this document is intended for use with the antimicrobial susceptibility testing procedures published in the following Clinical and Laboratory Standards Institute (CLSI)–approved standards.
Journal ArticleDOI
Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis.
Evelina Tacconelli,Elena Carrara,Alessia Savoldi,Stéphan Juergen Harbarth,Marc Mendelson,Dominique L Monnet,Céline Pulcini,Gunnar Kahlmeter,Jan Kluytmans,Yehuda Carmeli,Marc Ouellette,Kevin Outterson,Jean B. Patel,Marco Cavaleri,Edward Cox,Christopher R. Houchens,M Lindsay Grayson,Paul Hansen,Nalini Singh,Ursula Theuretzbacher,Nicola Magrini,Aaron O. Aboderin,Seif Al-Abri,Nordiah Awang Jalil,Nur Benzonana,Sanjay Bhattacharya,Adrian Brink,Francesco Robert Burkert,Otto Cars,Giuseppe Cornaglia,Oliver J. Dyar,Alexander W. Friedrich,Ana Cristina Gales,Sumanth Gandra,Christian G. Giske,Debra A. Goff,Herman Goossens,Thomas Gottlieb,Manuel Guzman Blanco,Waleria Hryniewicz,Deepthi Kattula,Timothy Jinks,Souha S. Kanj,Lawrence Kerr,Marie-Paule Kieny,Yang Soo Kim,Roman S. Kozlov,Jaime Labarca,Ramanan Laxminarayan,Karin Leder,Leonard Leibovici,Gabriel Levy-Hara,Jasper Littman,Surbhi Malhotra-Kumar,Vikas Manchanda,Lorenzo Moja,Babacar Ndoye,Angelo Pan,David L. Paterson,Mical Paul,Haibo Qiu,Pilar Ramon-Pardo,Jesús Rodríguez-Baño,Maurizio Sanguinetti,Sharmila Sengupta,Mike Sharland,Massinissa Si-Mehand,Lynn L. Silver,Wonkeung Song,Martin Steinbakk,Jens Thomsen,Guy E. Thwaites,Jos W. M. van der Meer,Nguyen Van Kinh,Silvio Vega,Maria Virginia Villegas,Agnes Wechsler-Fördös,Heiman F. L. Wertheim,Evelyn Wesangula,Neil Woodford,Fidan O Yilmaz,Anna Zorzet +81 more
TL;DR: Future development strategies should focus on antibiotics that are active against multidrug-resistant tuberculosis and Gram-negative bacteria, and include antibiotic-resistant bacteria responsible for community-acquired infections.
Journal ArticleDOI
Global Epidemiology of Campylobacter Infection
TL;DR: Overall, campylobacteriosis is still one of the most important infectious diseases that is likely to challenge global health in the years to come.
Journal ArticleDOI
Campylobacter, from obscurity to celebrity
TL;DR: In industrialised countries, the incidence of C. jejuni/Campylobacter coli infections peaks during infancy, and again in young adults aged 15-44 years, while in developing countries, inadequately treated water and contact with farm animals are the most important risk factors.
Journal ArticleDOI
Rapid identification by PCR of the genus Campylobacter and of five Campylobacter species enteropathogenic for man and animals
TL;DR: The nucleotide sequences for the 16S ribosomal RNA gene were compared for 33 species comprising the epsilon subdivision of the Proteobacteria (genera: Campylobacteria, Helicobacter, Arcobacter and Wolinella) and regions specific for the genus Campylabacter and for five Campyloblacter species important in human and/or veterinary medicine were identified.